Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (Nrf2): Role of antioxidant, anti-inflammatory, and antiapoptotic mechanisms
Ana Karina Aranda‐Rivera(Universidad Nacional Autónoma de México), José Pedraza‐Chaverrí(Universidad Nacional Autónoma de México), Isabel Amador‐Martínez(Universidad Nacional Autónoma de México), Edilia Tapia(Instituto Nacional de Cardiología), Laura Gabriela Sánchez‐Lozada(Instituto Nacional de Cardiología), Alfredo Cruz‐Gregorio(Instituto Nacional de Cardiología), Juan Carlos León‐Contreras(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Omar Noel Medina‐Campos(Universidad Nacional Autónoma de México), Bismarck Bernabe-Yepes(Instituto Nacional de Cardiologia), Omar Emiliano Aparicio‐Trejo(Instituto Nacional de Cardiología), Misael Garcia-Garcia(Instituto Nacional de Cardiologia), Rogélio Hernández‐Pando(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán)
Cited by 14
Related Papers
Uric acid and chronic kidney disease: which is chasing which?
|Nephrology Dialysis Transplantation|2013|644
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy
|Clinical Journal of the American Society of Nephrology|2016|473
RONS and Oxidative Stress: An Overview of Basic Concepts
|Oxygen|2022|354
Mitochondrial Redox Signaling and Oxidative Stress in Kidney Diseases
|Biomolecules|2021|221